Association between Blood Lead Levels and Silent Myocardial Infarction in the General Population

Area of Science:

• Environmental Health
• Cardiovascular Disease Epidemiology
• Toxicology

Background:

• Cardiovascular disease (CVD) is a known health concern, but the specific link between lead exposure and silent myocardial infarction (SMI) is not well understood.
• Lead exposure is a modifiable environmental risk factor with potential implications for cardiovascular health.

Purpose of the Study:

• To investigate the association between blood lead levels (BLLs) and the risk of developing silent myocardial infarction (SMI).

Main Methods:

• Analysis of data from 7283 participants without prior CVD from the Third National Health and Nutrition Examination Survey.
• Blood lead levels (BLLs) were quantified using graphite-furnace atomic absorption spectrophotometry.
• Silent myocardial infarction (SMI) was identified by ECG evidence in individuals with no prior history of myocardial infarction (MI), using multivariable logistic regression.

Main Results:

• A prevalence of 1.65% for SMI was observed in the study cohort.
• Higher BLLs demonstrated a positive correlation with increased SMI prevalence.
• Participants in the highest BLL tertile exhibited more than double the odds of SMI (OR: 3.42) compared to those in the lowest tertile. Each 1 µg/dL increase in BLL was associated with a 9% rise in SMI risk.

Conclusions:

• Elevated blood lead levels are significantly associated with increased odds of silent myocardial infarction in the general adult population.
• These findings highlight the importance of public health initiatives aimed at reducing lead exposure.
• The study suggests considering screening for SMI in populations with higher lead exposure levels.